✦ LIBER ✦

527 Neoadjuvant multimodal treatment approach for stage III non-small cell lung cancer (NSCLC): Results of a prospective phase II trial

✍ Scribed by Thomas, M.; Rübe, C.; Semik, M.; Klinke, F.; von Eiff, M.; van de Loo, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

241 Phase III trial of neoadjuvant and c

✍ Niell, H.B.; Miller, A.A.; Kumar, P.; Griffin, J.P. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Endpoints for multimodal clinical trials

✍ Green, M.R.; Cox, J.D.; Ardizzoni, A.; Arriagada, R.; Bureau, G.; Darwish, S.; D 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Docetaxel plus cisplatin as neoadjuvant

✍ Dediu, M; Horvat, T; Tarlea, A; Nicodin, A; Movanu, M; Radult, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Results of Surgical Treatment After Neoa

✍ Angelo Carretta; Paola Ciriaco; Giulio Melloni; Imad Sayed; Alessandro Bandiera; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 215 KB

Phase II trial of mitomycin, vindesine a

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 99 KB

A phase II study of Neoadjuvant Chemothe

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 143 KB